Adverse Reactions Occurring in 2% of SAXENDA-treated Adult Patients and More Frequently than Placebo 1 The most common reactions, each reported by 1% to 2.5% of SAXENDA-treated patients and more commonly than by placebo-treated patients, included erythema, pruritus, and rash at the injection site
Moreover, GLP-1 drugs such as semaglutide and liraglutide have demonstrated strong efficacy in improving glycemic control
Animal studies employed still different approaches scaled by body weight
They also said their hair felt stronger, shiner and smoother
doi: 10.3389/fimmu.2026.1753617 Received 25 November 2025 Revised 28 December 2025 Accepted 02 January 2026 Published 21 January 2026 Volume 17 - 2026 Edited by Leandro J
Regular supplementation with vitamin C (0.25 to 2 g/day) did not reduce the incidence of colds in the general population (23 trials)